Share
Journal Information
Most often read
333
“Methodological notes”: a new and important section in Clínica e Investigación en ArteriosclerosisJosep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Investig Arterioscler. 2023;35:243
333
Full text access
Open Article
202
Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift workRocío Mateo-Gallego, Sofía Pérez-Calahorra, Ana M. Bea, Irene Gracia-Rubio, Carmen Rodrigo-Carbo, Belen Moreno-Franco, Fernando Civeira, Martín Laclaustra, Itziar Lamiquiz-Moneo
Clin Investig Arterioscler. 2023;35:226-35
202
158
Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV studyElena M. Yubero-Serrano, Francisco M. Gutiérrez-Mariscal, Purificación Gómez-Luna, Juan F. Alcalá-Diaz, Pablo Pérez-Martinez, José López-Miranda
Clin Investig Arterioscler. 2023;35:105-14
158
126
Health-related lifestyle assessment among Spanish adults from 22 to 72 yearsPedro Luis Rodríguez García, Juan José Pérez Soto, Eliseo García Cantó, Marcos Meseguer Zafra, Raúl Salmerón Ríos, Pedro Juan Tárraga López
Clin Investig Arterioscler. 2023;35:12-20
126
Open Article
117
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primerMaría A. Zuriaga, José J. Fuster
Clin Investig Arterioscler. 2023;35:35-41
117
Open Article
92
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptorSusana Martín-Vañó, Alejandra Miralles-Abella, Pascual Castaño, Gema Hurtado-Genovés, María Aguilar-Ballester, Andrea Herrero-Cervera, Angela Vinué, Sergio Martínez-Hervás, Herminia González-Navarro
Clin Investig Arterioscler. 2023;35:1-11
92
Open Article
70
Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndromeMagda R. Hamczyk, Rosa M. Nevado
Clin Investig Arterioscler. 2023;35:42-51
70
Open Article
64
Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD studyAntonio Ruiz-Garcia, Ezequiel Arranz-Martínez, Nerea Iturmendi-Martínez, Teresa Fernández-Vicente, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez
Clin Investig Arterioscler. 2023;35:64-74
64
Open Article
62
Consensus document for lipid profile determination and reporting in Spanish clinical laboratoriesTeresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular
Clin Investig Arterioscler. 2023;35:91-100
62
Open Article
61
Arterial ageing and atherosclerotic risk: new perspectivesVicente Lahera Juliá, Ana M. Lahera García
Clin Investig Arterioscler. 2023;35:32-4
61
Open Article
53
Geostatistical analysis from the clinical laboratory in cardiovascular prevention for primary careSalomón Martín Pérez, Teresa Arrobas Velilla, Juan Fabiani de la Iglesia, Ignacio Vázquez Rico, Gema Varo Sánchez, Antonio León-Justel
Clin Investig Arterioscler. 2023;35:75-84
53
Open Article
50
Eating frequency has an inverse correlation with adiposity measures and non-invasive arterial stiffness parameters in healthy adult peopleSajjad Arefinia, Lida Jarahi, Hamed Khedmatgozar, Saeed Eslami Hasan Abadi, Mohammad Reza Shadmand Foumani Moghadam, André Tchernof, Hosein Soleimaninia, Reza Rezvani
Clin Investig Arterioscler. 2023;35:21-31
50
Open Article
40
Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast MexicoValeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera
Clin Investig Arterioscler. 2023;35:53-63
40
Open Article
37
Nutrition, cardiovascular disease risk and climate changeCarlos A. González Svatetz
Clin Investig Arterioscler. 2023;35:101-3
37
Open Article
26
Evolocumab como tratamiento de la dislipemia secundaria a lorlatinibLaura Pérez Alonso, Raquel Cervera Calero, María Ángeles Campos Fernández de Sevilla, Miguel Ángel Moreno Palanco, Jorge Francisco Gómez Cerezo
Clin Investig Arterioscler. 2023;35:88-90
26
Open Article
24
A step forward in the consensus on lipid profile characteristics for cardiovascular preventionXavier Pintó, Juan Pedro-Botet
Clin Investig Arterioscler. 2023;35:85-7
24
Open Article
1
Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in ColombiaÁngel Alberto García-Peña, Mariana Pineda-Posada, Carol Páez-Canro, César Cruz, Daniel Samacá-Samacá
Clin Investig Arterioscler. 2023;35:280-9
1